Sleep and Exercise for Alzheimer's Disease
(CASE Trial)
Trial Summary
What is the purpose of this trial?
This trial is studying whether better sleep and more exercise can reduce the risk of dementia in people who are at risk. The idea is that these lifestyle changes might help keep the brain healthy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment for Alzheimer's disease?
Is it safe for humans to use exercise and devices like the Dreem 2 Headband and Fitbit for Alzheimer's disease?
How does the exercise routine treatment for Alzheimer's differ from other treatments?
The exercise routine treatment for Alzheimer's is unique because it focuses on improving sleep quality and cognitive function through physical activity, rather than using medication. This approach leverages the benefits of exercise on sleep efficiency and overall health, which may help reduce the risk of Alzheimer's disease.1011121314
Research Team
Azizi A Seixas, PhD
Principal Investigator
University of Miami
Eligibility Criteria
This trial is for individuals experiencing memory, concentration, or information processing issues who can do mild exercise and wear a DREEM 2 Headband and Fitbit watch. They must be able to handle a digital device and perform the Everlywell biomarker test. Participants should speak English and consent willingly.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in sleep and/or exercise interventions for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- DREEM 2 Headband (Procedure)
- Exercise Routine (Behavioural Intervention)
- Fitbit (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Dr. Alec C. Kimmelman
NYU Langone Health
Chief Executive Officer
MD and PhD from Mount Sinai School of Medicine
Dr. Nicole M. Adler
NYU Langone Health
Chief Medical Officer since 2023
MD
University of Miami
Lead Sponsor
Sylvia Daunert
University of Miami
Chief Executive Officer since 2011
PhD in Biochemistry and Molecular Biology, University of Kentucky
Bahar Motlagh
University of Miami
Chief Medical Officer since 2021
PhD in Biomedical Engineering, Ecole Polytechnique Montreal
Dreem
Industry Sponsor
Shipley Foundation
Collaborator